The authors exclusively Observe The shortage of randomized controlled trials for orthopaedic indications—which means we can’t confidently say it really works, what the true aspect-impact profile is, or what a “safe dose” will be in the real world (systematic evaluate, 2024). If your goal is “much less downtime, additional training,” https://theodoro504wkv3.wikicorrespondence.com/user